These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 22434105

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effects of C-terminal truncation of receptor activity modifying proteins on the induction of amylin receptor phenotype from human CTb receptors.
    Udawela M, Christopoulos G, Morfis M, Tilakaratne N, Christopoulos A, Sexton PM.
    Regul Pept; 2008 Jan 10; 145(1-3):65-71. PubMed ID: 17884192
    [Abstract] [Full Text] [Related]

  • 25. Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors.
    Morfis M, Tilakaratne N, Furness SG, Christopoulos G, Werry TD, Christopoulos A, Sexton PM.
    Endocrinology; 2008 Nov 10; 149(11):5423-31. PubMed ID: 18599553
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Inhibitory effects of two G protein-coupled receptor kinases on the cell surface expression and signaling of the human adrenomedullin receptor.
    Kuwasako K, Sekiguchi T, Nagata S, Jiang D, Hayashi H, Murakami M, Hattori Y, Kitamura K, Kato J.
    Biochem Biophys Res Commun; 2016 Feb 19; 470(4):894-9. PubMed ID: 26820533
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Modulating receptor function through RAMPs: can they represent drug targets in themselves?
    Sexton PM, Poyner DR, Simms J, Christopoulos A, Hay DL.
    Drug Discov Today; 2009 Apr 19; 14(7-8):413-9. PubMed ID: 19150656
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Identification and pharmacological characterization of domains involved in binding of CGRP receptor antagonists to the calcitonin-like receptor.
    Salvatore CA, Mallee JJ, Bell IM, Zartman CB, Williams TM, Koblan KS, Kane SA.
    Biochemistry; 2006 Feb 14; 45(6):1881-7. PubMed ID: 16460034
    [Abstract] [Full Text] [Related]

  • 38. Localization of calcitonin receptor-like receptor and receptor activity modifying protein 1 in enteric neurons, dorsal root ganglia, and the spinal cord of the rat.
    Cottrell GS, Roosterman D, Marvizon JC, Song B, Wick E, Pikios S, Wong H, Berthelier C, Tang Y, Sternini C, Bunnett NW, Grady EF.
    J Comp Neurol; 2005 Sep 26; 490(3):239-55. PubMed ID: 16082677
    [Abstract] [Full Text] [Related]

  • 39. Aspartate(69) of the calcitonin-like receptor is required for its functional expression together with receptor-activity-modifying proteins 1 and -2.
    Ittner LM, Luessi F, Koller D, Born W, Fischer JA, Muff R.
    Biochem Biophys Res Commun; 2004 Jul 09; 319(4):1203-9. PubMed ID: 15194494
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.